JOSÉ ÁNGEL
HERNÁNDEZ RIVAS
Profesor asociado de Ciencias de la Salud
University of Belgrade
Belgrado, SerbiaPublicaciones en colaboración con investigadores/as de University of Belgrade (4)
2023
-
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
International Journal of Antimicrobial Agents, Vol. 62, Núm. 4
-
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
eClinicalMedicine, Vol. 58
2021
-
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
Blood, Vol. 138, Núm. 18, pp. 1768-1773
2020
-
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Blood, Vol. 136, Núm. 10, pp. 1134-1143